Author:
Brunaugh Ashlee D.,Moraga-Espinoza Daniel,Bahamondez-Canas Tania,Smyth Hugh D. C.,Williams Robert O.
Publisher
Springer International Publishing
Reference6 articles.
1. Muralidhara BK, Wong M. Critical considerations in the formulation development of parenteral biologic drugs. Drug Discov Today. 2020a;25(3):574–81.
2. Muralidhara BK, Wong M. Critical considerations in the formulation development of parenteral biologic drugs. Drug Discov Today. 2020b;25(3):574–81. https://doi.org/10.1016/j.drudis.2019.12.011.
3. US Food and Drug Administration (FDA). Purple book database of licensed biological products (6 February 2018). Available at https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/what-are-biologics-questions-and-answers. Accessed 14 Aug 2023.
4. US Food and Drug Administration (FDA). What are “Biologics” questions and answers (9 August 2023). Available at https://purplebooksearch.fda.gov/. Accessed 14 Aug 2023.
5. Williams RO III. Improved formulations to enable stable delivery of biologics. BioPharm Int. 2022;35(7):46–9.